Age-related macular degeneration: the optometrist's role in detection and management

18 November 2014
Volume 15, Issue 4

The role of optometrist in the detection and management of AMD in the UK and Australia.

Introduction 

Age-related macular degeneration (AMD) is a leading cause of global blindness and vision impairment (Pascolini and Mariotti 2012). In the UK nearly 60% of cases of registered sight impairment and severe sight impairment are attributable to AMD (Bunce et al. 2010). Similarly, in Australia, the synthesis of data from the Melbourne Visual Impairment Project and the Blue Mountains Eye Study indicates that AMD is responsible for almost half of all cases of ‘blindness’ (Taylor et al. 2005). Around 600 000 people in the UK have AMD, a figure that is expected to rise to around 750 000 by 2020 (Minassian et al. 2011). 

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

A glance at what’s happening in the world of technology - Spring 2023.

As age-related macular degeneration progresses, part of the visual cortex starts to atrophy. But which way does the causal relationship work, asks Kim Thomas, and what does it mean for treatments focused on the retina if the brain has entered an irreversible decline?

The effort, cost and logistics of managing treatment for eye conditions can have a big impact on patients’ quality of life. What can be done to minimise their treatment burden?